Söderpalm B, Engel J A
Department of Pharmacology, University of Göteborg, Sweden.
Pharmacol Biochem Behav. 1988 Jun;30(2):471-7. doi: 10.1016/0091-3057(88)90482-0.
The effect of the alpha-2-adrenoceptor agonist clonidine on anxiety-related behavior was investigated using two different rat anxiety models: a modified Vogel's drinking conflict model and Montgomery's elevated plus-maze. In both models biphasic dose-response curves were obtained; in a narrow low-dose range (6.25-10.0 micrograms/kg) the drug produced anxiolytic-like effects, while anxiogenic-like properties were found after higher doses (12.5-80.0 micrograms/kg). Attempts to block the effects obtained were made in Montgomery's elevated plus-maze. The specific alpha-2-adrenoceptor antagonist idazoxan blocked the anxiolytic-like effect but did not influence the anxiogenic-like activity. Conversely, the specific alpha-1-adrenoceptor antagonist prazosin blocked the anxiogenic-like effect but did not alter the anxiolytic-like activity. These findings may suggest that alpha-1- and alpha-2-adrenergic receptor mechanisms are reciprocally involved in anxiety-related behavior.
使用两种不同的大鼠焦虑模型,研究了α-2肾上腺素能受体激动剂可乐定对焦虑相关行为的影响:改良的Vogel饮水冲突模型和蒙哥马利高架十字迷宫。在这两种模型中均获得了双相剂量反应曲线;在狭窄的低剂量范围(6.25 - 10.0微克/千克)内,该药物产生抗焦虑样作用,而在较高剂量(12.5 - 80.0微克/千克)后则发现有促焦虑样特性。在蒙哥马利高架十字迷宫中尝试阻断所获得的效应。特异性α-2肾上腺素能受体拮抗剂咪唑克生阻断了抗焦虑样效应,但不影响促焦虑样活性。相反,特异性α-1肾上腺素能受体拮抗剂哌唑嗪阻断了促焦虑样效应,但未改变抗焦虑样活性。这些发现可能表明α-1和α-2肾上腺素能受体机制相互参与焦虑相关行为。